Carbapenemases From 2017 to 2019, it was specified whether a test for carbapenemase genes was performed in the laboratory on average for 51% of CRA and for 52% of CRE cases with an increasing trend over the years.
← all excerpts
Geographical differences of carbapenem non-susceptible Enterobacterales and Acinetobacter spp. in Germany from 2017 to 2019.
1
—
—